Research Classification
Research Interests
Relevant Thesis-Based Degree Programs
Affiliations to Research Centres, Institutes & Clusters
Research Options
Research Methodology
Recruitment
Complete these steps before you reach out to a faculty member!
Check requirements
- Familiarize yourself with program requirements. You want to learn as much as possible from the information available to you before you reach out to a faculty member. Be sure to visit the graduate degree program listing and program-specific websites.
- Check whether the program requires you to seek commitment from a supervisor prior to submitting an application. For some programs this is an essential step while others match successful applicants with faculty members within the first year of study. This is either indicated in the program profile under "Admission Information & Requirements" - "Prepare Application" - "Supervision" or on the program website.
Focus your search
- Identify specific faculty members who are conducting research in your specific area of interest.
- Establish that your research interests align with the faculty member’s research interests.
- Read up on the faculty members in the program and the research being conducted in the department.
- Familiarize yourself with their work, read their recent publications and past theses/dissertations that they supervised. Be certain that their research is indeed what you are hoping to study.
Make a good impression
- Compose an error-free and grammatically correct email addressed to your specifically targeted faculty member, and remember to use their correct titles.
- Do not send non-specific, mass emails to everyone in the department hoping for a match.
- Address the faculty members by name. Your contact should be genuine rather than generic.
- Include a brief outline of your academic background, why you are interested in working with the faculty member, and what experience you could bring to the department. The supervision enquiry form guides you with targeted questions. Ensure to craft compelling answers to these questions.
- Highlight your achievements and why you are a top student. Faculty members receive dozens of requests from prospective students and you may have less than 30 seconds to pique someone’s interest.
- Demonstrate that you are familiar with their research:
- Convey the specific ways you are a good fit for the program.
- Convey the specific ways the program/lab/faculty member is a good fit for the research you are interested in/already conducting.
- Be enthusiastic, but don’t overdo it.
Attend an information session
G+PS regularly provides virtual sessions that focus on admission requirements and procedures and tips how to improve your application.
ADVICE AND INSIGHTS FROM UBC FACULTY ON REACHING OUT TO SUPERVISORS
These videos contain some general advice from faculty across UBC on finding and reaching out to a potential thesis supervisor.
Graduate Student Supervision
Master's Student Supervision
Theses completed in 2010 or later are listed below. Please note that there is a 6-12 month delay to add the latest theses.
Introduction: Mood and anxiety disorders are the most prevalent mental health disorders worldwide; they can cause significant physical distress and impaired functioning. In Canada, quantifying and describing the impact of these disorders is a priority. Objectives: (1) To explore the trends in the prevalence of mood and/or anxiety disorders by geographical regions in Canada, and to assess key determinants of health associated with mental health disparities across these regions. (2) To assess whether food security, access to regular medical doctor, and sense of belonging to the community mediate the relationship between mood and/or anxiety disorders and general health satisfaction.Methods: This serial cross-sectional study used data from a nationally representative sample of Canadians, aged 18-59, from the Canadian Community Health Survey, annual cycles 2011-2016. Bivariate relationships were examined using chi-square tests for categorical variables and t-tests for continuous variables. Adjusted logistic regression models were used to identify which factors were associated with the prevalence of mood and/or anxiety disorders (using SAS 9.4). Mediation models were based on the Sobel product of coefficients approach (using Stata version 13).Results: The prevalence of mood and/or anxiety disorders increased across all regions between 2011 and 2016, with Quebec consistently having the lowest prevalence, and the Atlantic region having the highest. In most regions, individuals who drank occasionally or regularly, males, immigrants, non-Caucasians and those with a strong sense of belonging to a community were less likely to be diagnosed with a mood and/or anxiety disorder. Across most regions, sexual orientation and food security were the characteristics associated with our outcome. In our second analysis, for most years, respondents who described having fair/poor general health satisfaction reported a weak sense of belonging to the community, being food insecure, and having a mood and/or anxiety disorder. In our mediation analysis, food security and sense of community belonging partially mediated the association between mood and/or anxiety diagnosis and general health satisfaction. Conclusions: This research provided new data for provincial governments to identify programs and policies that intervene to improve key health determinants associated with mood and/or anxiety disorders across regions in Canada.
View record
Publications
- Antiretroviral therapy use, self-reported adherence, and viral suppression among women living with HIV in Canada (2025)
HIV Medicine - Cohort Profile Update: Reflecting back and looking ahead: Updating the Comparative Outcomes and Service Utilization Trends (COAST) Study to include 28 years of linked data from people with and without HIV in British Columbia, Canada (2025)
International Journal of Population Data Science, 10 (1) - Generalized Treatment as Prevention Plus Focused Pre-Exposure Prophylaxis Is the Key to Controlling HIV/AIDS (2025)
Tropical Medicine and Infectious Disease, 10 (3) - Healthcare utilisation in people living with HIV: The role of substance use, mood/anxiety disorders and unsustained viral suppression - A retrospective cohort study in British Columbia, Canada, 2001-2019 (2025)
BMJ Open, 15 (3) - Impact of mental health service use on the HIV care cascade among women (2025)
HIV Medicine, 26 (5), 758-772 - Jointly modeling means and variances for nonlinear mixed effects models with measurement errors and outliers (2025)
Biometrics, 81 (1) - Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIV (2024)
Journal of Acquired Immune Deficiency Syndromes, 96 (4), 393-398 - Dynamics of overdose and non-overdose mortality among people living with HIV amidst the illicit drug toxicity crisis in British Columbia (2024)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 36 (2), 263-271 - Expanding access to healthcare for people who use drugs and sex workers: hepatitis C elimination implications from a qualitative study of healthcare experiences in British Columbia, Canada (2024)
Harm Reduction Journal, 21 (1) - IAPAC–Lancet HIV Commission on the future of urban HIV responses (2024)
The Lancet HIV - Impact of screening and doxycycline prevention on the syphilis epidemic among men who have sex with men in British Columbia: a mathematical modelling study (2024)
The Lancet Regional Health - Americas, 33 - Impact of Substance Use and Mood/Anxiety Disorders on the HIV Continuum of Care in British Columbia, Canada, from 2001 to 2019 (2024)
International Journal of Mental Health and Addiction - Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America (2024)
AIDS, 38 (9), 1366-1374 - Longitudinal evolution of the HIV effective reproduction number following sequential expansion of treatment as prevention and pre-exposure prophylaxis in British Columbia, Canada: a population-level programme evaluation (2024)
The Lancet HIV, 11 (7), e461-e469 - Retention in primary care among unstably housed residents of a low-income, inner-city neighborhood with a high prevalence of substance use and related disorders (2024)
International Journal for Equity in Health, 23 (1) - Secondary use of routinely collected administrative health data for epidemiologic research: Answering research questions using data collected for a different purpose (2024)
International Journal of Population Data Science, 9 (1) - The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study (2024)
PLoS Medicine, 21 (1) - The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: Are we ready for the next pandemic? (2024)
Social Science and Medicine, 350 - Healthcare utilisation and costs associated with adherence to antipsychotics among people living with HIV/AIDS and schizophrenia: A population-based cohort study in British Columbia, Canada (2023)
BMJ Open, 13 (4) - Hospital Readmissions Among Persons With Human Immunodeficiency Virus in the United States and Canada, 2005–2018: A Collaboration of Cohort Studies (2023)
Journal of Infectious Diseases, 228 (12), 1699-1708 - Identification of people with low prevalence diseases in administrative healthcare records: A case study of HIV in British Columbia, Canada (2023)
PLoS ONE, 18 (8 August) - Identifying Longitudinal CD4:CD8 Ratio Trajectories Indicative of Chronic Renal Disease Risk among People Living with HIV: An Application of Growth Mixture Models (2023)
Viruses, 15 (2) - Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine (2023)
American Journal of Epidemiology, 192 (8), 1341-1349 - Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada (2023)
PLoS ONE, 18 (3 March) - The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum (2023)
AIDS, 37 (2), 259-269 - A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders (2022)
AIDS, 36 (13), 1851-1860 - A province-wide HIV initiative to accelerate initiation of treatment-as-prevention and virologic suppression in British Columbia, Canada: a population-based cohort study (2022)
CMAJ open, 10 (1), E27-E34 - A two-day workshop reviewing Canadian provincial and national HIV care cascade indicators, reporting, challenges, and recommendations (2022)
JAMMI, 7 (3), 247-268 - Disability-adjusted life years associated with chronic comorbidities among people living with and without HIV: Estimating health burden in British Columbia, Canada (2022)
PLOS Global Public Health, 2 (10) - Discrimination and Calibration of the Veterans Aging Cohort Study Index 2.0 for Predicting Mortality among People with Human Immunodeficiency Virus in North America (2022)
Clinical Infectious Diseases, 75 (2), 297-304 - Erratum: Clinical Effectiveness of Integrase Strand Transfer Inhibitor-Based Antiretroviral Regimens among Adults with Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada (Clin Infect Dis (2020) DOI: 10.1093/cid/ciaa1037) (2022)
Clinical Infectious Diseases, 74 (4), 755 - Evolving patterns of antiretroviral drug interactions in people with HIV in British Columbia, Canada (2022)
AIDS, 36 (8), 1105-1115 - Help-Seeking to Cope With Experiences of Violence Among Women Living With HIV in Canada (2022)
Violence Against Women, 28 (3-4), 823-850 - Household food insecurity, sense of community belonging, and access to a regular medical doctor as mediators in the relationship between mood and/or anxiety disorders and self-rated general health in Canada between 2011 and 2016: a serial cross-sectional analysis (2022)
Canadian Journal of Public Health, 113 (6), 944-954 - Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population-based pre-exposure prophylaxis program in British Columbia, Canada (2022)
Liver International, 42 (7), 1528-1535 - Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States (2022)
Annals of Epidemiology, 65, 46-55 - Sexual minority status modifies the association between HIV risk behavior and prevalent mood or anxiety disorders in British Columbia, Canada (2022)
Social Psychiatry and Psychiatric Epidemiology, 57 (1), 207-218 - The impact of lookback windows on the prevalence and incidence of chronic diseases among people living with HIV: an exploration in administrative health data in Canada (2022)
BMC Medical Research Methodology, 22 (1) - Use of Gay Chatlines and Online Dating Platforms as Potential Mediators or Moderators in the Relationship Between Loneliness, Self-Rated Attractiveness and Human Immunodeficiency Virus Acquisition Risk Among Gay, Bisexual, and Other Men Who Have Sex With Men in Vancouver, Canada (2022)
Sexually Transmitted Diseases, 49 (10), 706-712 - Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy (2022)
AIDS, 36 (2), 277-286 - Can the combination of TasP and PrEP eliminate HIV among MSM in British Columbia, Canada? (2021)
Epidemics, 35 - CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018 (2021)
Clinical Infectious Diseases, 73 (7), E2334-E2337 - Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada (2021)
Open Forum Infectious Diseases, 8 (11) - Clinical Effectiveness of Integrase Strand Transfer Inhibitor–Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada (2021)
Clinical Infectious Diseases, 73 (7), E1408-E1414 - Correlates of social isolation among people living with HIV in British Columbia, Canada (2021)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 33 (5), 566-574 - Current and Past Immunodeficiency Are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years (2021)
Journal of Infectious Diseases, 224 (4), 657-666 - Disparities in multimorbidity and mortality among people living with and without HIV across British Columbia’s health regions: a population-based cohort study (2021)
Canadian Journal of Public Health, 112 (6), 1030-1041 - Estimation of time of HIV seroconversion using a modified CD4 depletion model (2021)
PLoS ONE, 16 (2 February) - Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: A population-based cohort study (2021)
BMJ Open, 11 (1) - Incidence of diabetes mellitus among people living with and without HIV in British Columbia, Canada between 2001 and 2013: A longitudinal population-based cohort study (2021)
BMJ Open, 11 (5) - Increased CD4:CD8 ratio normalization with implementation of current ART management guidelines (2021)
Journal of Antimicrobial Chemotherapy, 76 (3), 729-737 - Mortality among persons entering hiv care compared with the general u.s. population: An observational study (2021)
Annals of Internal Medicine, 174 (9), 1197-1206 - Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada (2021)
International Journal of Drug Policy, 96 - Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor–Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada (2021)
Clinical Infectious Diseases, 73 (7), E2234-E2242 - Social Isolation and Mortality Among People Living with HIV in British Columbia, Canada (2021)
AIDS and Behavior, 25 (2), 377-388 - A co-interaction model of HIV and syphilis infection among gay, bisexual and other men who have sex with men (2020)
Infectious Disease Modelling, 5, 855-870 - Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada (2020)
PLoS Medicine, 17 (7) - Sexual Anxiety Among Women Living with HIV in the Era of Antiretroviral Treatment Suppressing HIV Transmission (2020)
Sexuality Research and Social Policy, 17 (4), 765-779 - Social Determinants of Health and Retention in HIV Care Among Recently Incarcerated Women Living with HIV in Canada (2020)
AIDS and Behavior, 24 (4), 1212-1225 - The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, Canada (2020)
Current HIV/AIDS Reports, 17 (2), 77-87 - Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada (2020)
Journal of the International AIDS Society, 23 (4) - A Latent Class Analysis of the Social Determinants of Health Impacting Heavy Alcohol Consumption Among Women Living with HIV in Canada: The Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (2019)
AIDS and Behavior, 23 (12), 3226-3236 - A longitudinal study of associations between HIV-related stigma, recent violence and depression among women living with HIV in a Canadian cohort study (2019)
Journal of the International AIDS Society, 22 (7) - Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals with Sustained Virological Suppression on Antiretroviral Therapy (2019)
Journal of Acquired Immune Deficiency Syndromes, 80 (3), 292-300 - Exploring the live birth rates of women living with HIV in British Columbia, Canada (2019)
PLoS ONE, 14 (2) - High prevalence of abnormal menstruation among women living with HIV in Canada (2019)
PLoS ONE, 14 (12) - HIV, schizophrenia, and all-cause mortality: A population-based cohort study of individuals accessing universal medical care from 1998 to 2012 in British Columbia, Canada (2019)
Schizophrenia Research, 209, 198-205 - Impact of personality disorders on leaving hospital against medical advice among people living with HIV in British Columbia, Canada (2019)
Social Psychiatry and Psychiatric Epidemiology, 54 (9), 1153-1159 - Incidence of select chronic comorbidities among a population-based cohort of HIV-positive individuals receiving highly active antiretroviral therapy (2019)
Current Medical Research and Opinion, 35 (11), 1955-1963 - Love with HIV: A Latent Class Analysis of Sexual and Intimate Relationship Experiences Among Women Living with HIV in Canada (2019)
Archives of Sexual Behavior - Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study (2019)
PLoS ONE, 14 (3) - Overrepresentation of injection drug use route of infection among human immunodeficiency virus long-term nonprogressors: A nationwide, retrospective cohort study in China, 1989–2016 (2019)
Open Forum Infectious Diseases, 6 (5) - Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting (2019)
BMJ Open, 9 (3) - Prevalence of human immunodeficiency virus-1 integrase strand transfer inhibitor resistance in British Columbia, Canada between 2009 and 2016: A longitudinal analysis (2019)
Open Forum Infectious Diseases, 6 (3) - Retention in care and mortality trends among patients receiving comprehensive care for HIV infection: a retrospective cohort study (2019)
CMAJ open, 7 (2), E236-E245 - The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada (2019)
EClinicalMedicine, 13, 101-111 - The syndemic effect of HIV/HCV co-infection and mental health disorders on acute care hospitalization rate among people living with HIV/AIDS: a population-based retrospective cohort study (2019)
Canadian Journal of Public Health, 110 (6), 779-791 - Adverse drug reactions to integrase strand transfer inhibitors (2018)
AIDS, 32 (7), 903-912 - Assessing the relationship between physician availability and viral load suppression in British Columbia (2018)
Canadian Geographer, 62 (2), 120-129 - Cohort profile: The Comparative Outcomes and Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada (2018)
BMJ Open, 8 (1) - Correction: Disparities in the burden of HIV/AIDS in Canada (PLoS ONE (2012) 7:11 (e47260) DOI: 10.1371/journal.pone.0047260) (2018)
PLoS ONE, 13 (12) - Distance to HIV care and treatment adherence: Adjusting for socio-demographic and geographical heterogeneity (2018)
Spatial and Spatio-temporal Epidemiology, 27, 29-35 - Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach (2018)
Journal of Viral Hepatitis, 25 (1), 28-36 - Identifying risk of viral failure in treated hiv-infected patients using different measures of adherence: the antiretroviral therapy cohort collaboration (2018)
Journal of Clinical Medicine, 7 (10) - Innovative multimodal training program for family physicians leads to positive outcomes among their HIV-positive patients (2018)
Journal of Continuing Education in the Health Professions, 38 (1), 60-65 - Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio (2018)
AIDS, 32 (10), 1361-1367 - Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996–2016 (2018)
Clinical Microbiology and Infection, 24 (2), 185-191 - The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: A retrospective cohort study (2018)
BMC Health Services Research, 18 (1) - A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada (2017)
HIV Medicine, 18 (9), 655-666 - An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition (2017)
HIV Medicine, 18 (5), 342-353 - CD4:CD8 Ratio and CD8 Count as prognostic markers for mortality in human immunodeficiency virus-infected patients on antiretroviral therapy: The antiretroviral therapy cohort collaboration (ART-CC) (2017)
Clinical Infectious Diseases, 65 (6), 959-966 - Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012 (2017)
BMC Infectious Diseases, 17 (1) - Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients (2017)
BMC Infectious Diseases, 17 (1) - Emergent drug resistance with integrase strand transfer inhibitor-based regimens (2017)
AIDS, 31 (10), 1425-1434 - Envisioning Women-Centered HIV Care: Perspectives from Women Living with HIV in Canada (2017)
Women's Health Issues, 27 (6), 721-730 - Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification (2017)
PLoS ONE, 12 (2) - Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load (2017)
Journal of Antimicrobial Chemotherapy, 72 (2), 496-503 - Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study (2017)
The Lancet HIV, 4 (6), e270-e276 - Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy (2017)
BMC Infectious Diseases, 17 (1) - Hepatitis C testing in Canada: Don't leave baby boomers behind (2017)
CMAJ, 189 (25), E870-E871 - Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50 (2017)
BMJ Open Diabetes Research and Care, 5 (1) - Increased mortality among indigenous persons in a multisite cohort of people living with HIV in Canada (2017)
Canadian Journal of Public Health, 108 (2), e169-e175 - Is there a rural/urban gap in the quality of HIV care for treatment-naïve HIV-positive individuals initiating antiretroviral therapy in British Columbia? (2017)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 29 (10), 1218-1226 - Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches (2017)
AIDS, 31 (17), 2345-2354 - Progress towards the United Nations 90-90-90 and 95-95-95 targets: The experience in British Columbia, Canada (2017)
Journal of the International AIDS Society, 20 (3) - Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapy (2017)
HIV Medicine, 18 (3), 151-160 - Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996–2013: a modelling study (2017)
The Lancet HIV, 4 (7), e303-e310 - Conditions for eradicating hepatitis C in people who inject drugs: A fibrosis aware model of hepatitis C virus transmission (2016)
Journal of Theoretical Biology, 395, 31-39 - Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function: (2016)
Journal of the International AIDS Society, 19 (1) - Erratum: Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes (AIDS (2015) 29 (1871-1882)) (2016)
AIDS, 30 (4), 677 - Establishing the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS): Operationalizing Community-based Research in a Large National Quantitative Study (2016)
BMC Medical Research Methodology, 16 (1) - Heightened epidemic in men who have sex with men in Brazil (2016)
The Lancet HIV, 3 (10), e454-e455 - Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: Implications for first-line therapy choice in resource-limited settings: Implications (2016)
Journal of the International AIDS Society, 19 (1) - Non-HIV-related health care utilization, demographic, clinical and laboratory factors associated with time to initial retention in HIV care among HIV-positive individuals linked to HIV care (2016)
HIV Medicine, 17 (4), 269-279 - Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4 + cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda (2016)
AIDS, 30 (11), 1781-1788 - Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001–2012 (2016)
HIV Medicine, 17 (9), 694-701 - Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada (2016)
Journal of Hepatology, 64 (6), 1247-1255 - Absolute leukocyte telomere length in HIV-infected and uninfected individuals: Evidence of accelerated cell senescence in HIV-associated chronic obstructive pulmonary disease (2015)
PLoS ONE, 10 (4) - AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: A retrospective study (2015)
The Lancet HIV, 2 (3), e92-e97 - Are interferon-free direct-acting antivirals for the treatment of HCV enough to control the epidemic among people who inject drugs? (2015)
PLoS ONE, 10 (12) - Characterizing retention in HAART as a recurrent event process: Insights into 'cascade churn' (2015)
AIDS, 29 (13), 1681-1689 - Cohort profile: HAART observational medical evaluation and research (HOMER) cohort (2015)
International Journal of Epidemiology, 44 (1), 58-67 - Cost-eff ectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: A modelling study (2015)
The Lancet HIV, 2 (9), e393-e400 - Costs of Health Resource Utilization Among HIV-Positive Individuals in British Columbia, Canada: Results From a Population-Level Study (2015)
PharmacoEconomics, 33 (3), 243-253 - Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤200cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤200cells/μL in British Columbia, Canada (2015)
HIV Medicine, 16 (6), 337-345 - Erratum: Correction: The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model (PLoS ONE (2015) 10:5 (e0128734) doi:10.1371/journal.pone.0128734) (2015)
PLoS ONE, 10 (5) - Estimating the impact of earlier ART initiation and increased testing coverage on HIV transmission among men who have sex with men in Mexico using a mathematical model (2015)
PLoS ONE, 10 (8) - Factors associated with the frequency of monitoring of liver enzymes, renal function and lipid laboratory markers among individuals initiating combination antiretroviral therapy: A cohort study (2015)
BMC Infectious Diseases, 15 (1) - IAPAC guidelines for optimizing the HIV care continuum for adults and adolescents (2015)
Journal of the International Association of Providers of AIDS Care, 14, S3-S34 - Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes (2015)
AIDS, 29 (14), 1871-1882 - Late initiation of combination antiretroviral therapy in Canada: A call for a national public health strategy to improve engagement in HIV care (2015)
Journal of the International AIDS Society, 18 (1) - Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada (2015)
BMC Infectious Diseases, 15 (1) - Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada (2015)
Drug and Alcohol Dependence, 152, 272-276 - The 'Expanded HIV care in opioid substitution treatment' (EHOST) cluster-randomized, stepped-wedge trial: A study protocol (2015)
Contemporary Clinical Trials, 45, 201-209 - The causal effect of opioid substitution treatment on HAART medication refill adherence (2015)
AIDS, 29 (8), 965-973 - The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality among HIV-Positive People Who Inject Drugs (2015)
Clinical Infectious Diseases, 61 (7), 1157-1165 - The impact of implementing a test, treat and retain HIV prevention strategy in Atlanta among black men who have sex with men with a history of incarceration:A mathematical model (2015)
PLoS ONE, 10 (4) - The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting (2015)
Drug and Alcohol Dependence, 156, 57-61 - The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada (2015)
Journal of the International AIDS Society, 18 (1) - The need for standardisation of the HIV continuum of care (2015)
The Lancet HIV, 2 (6), e225-e226 - Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: A retrospective cohort study (2015)
BMC Health Services Research, 15 (1) - Antiretroviral drug costs and prescription patterns in British Columbia, Canada 1996-2011 (2014)
Medical Care, 52 (4), 362-369 - Cohort profile: Seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC) (2014)
International Journal of Epidemiology, 43 (4), 1073-1081 - Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years (2014)
Journal of the International AIDS Society, 17 - Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012 (2014)
PLoS ONE, 9 (6) - Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and hiv transmission: The "HIV treatment as prevention" experience in a Canadian setting (2014)
PLoS ONE, 9 (2) - Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000-2010) (2014)
PLoS ONE, 9 (3) - High levels of heterogeneity in the hiv cascade of care across different population subgroups in British Columbia, Canada (2014)
PLoS ONE, 9 (12) - How can we get close to zero? The potential contribution of biomedical prevention and the investment Framework towards an effective response to HIV (2014)
PLoS ONE, 9 (11) - Modeling scenarios for the end of AIDS (2014)
Clinical Infectious Diseases, 59 (SUPPL.1) - Modelling clinical progression and health care utilization of HIV-positive patients in British Columbia prior to death (2014)
HIV Medicine, 15 (9), 557-564 - Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals (2014)
Clinical Infectious Diseases, 58 (8), 1165-1173 - Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada (2014)
Hepatology, 60 (5), 1571-1580 - Process monitoring of an HIV Treatment as Prevention program in British Columbia, Canada (2014)
Journal of Acquired Immune Deficiency Syndromes, 67 (3), e94-e109 - Temporal trends in the discontinuation of first-line antiretroviral therapy (2014)
Journal of Antimicrobial Chemotherapy, 69 (8), 2202-2209 - The cascade of HIV care in British Columbia, Canada, 1996-2011: A population-based retrospective cohort study (2014)
The Lancet Infectious Diseases, 14 (1), 40-49 - The determinants of poor respiratory health status in adults living with human immunodeficiency virus infection (2014)
AIDS Patient Care and STDs, 28 (5), 240-247 - The effect of history of injection drug use and alcoholism on HIV disease progression (2014)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 26 (1), 123-129 - The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users (2014)
Addiction, 109 (12), 2053-2059 - Tuberculosis in HIV-infected persons in British Columbia during the HAART era (2014)
Canadian Journal of Public Health, 105 (4) - "Test-and-treat" strategy for control of HIV and AIDS can lead to a decrease, not an increase, of multidrug-resistant viruses (2013)
Clinical Infectious Diseases, 57 (3), 478-479 - Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada (2013)
PLoS ONE, 8 (1) - Characterizing durations of heroin abstinence in the California civil addict program: Results from a 33-year observational cohort study (2013)
American Journal of Epidemiology, 177 (7), 675-682 - Evaluation of treatment tolerability, satisfaction and laboratory parameters in HIV+ patients switching from ritonavir capsule to tablet formulation (2013)
Current HIV Research, 11 (3), 231-237 - Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria (2013)
AIDS, 27 (7), 1159-1165 - Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: A multisite cohort study (2013)
PLoS ONE, 8 (12) - Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals (2013)
Hepatology, 58 (5), 1598-1609 - HIV-1 disease progression during highly active antiretroviral therapy: An application using population-level data in British Columbia: 1996-2011 (2013)
Journal of Acquired Immune Deficiency Syndromes, 63 (5), 653-659 - Intergenerational sex as a risk factor for HIV among young men who have sex with men: A scoping review (2013)
Current HIV/AIDS Reports, 10 (4), 398-407 - Potential impact of the us president's emergency plan for AIDS relief on the tuberculosis/HIV coepidemic in selected sub-Saharan African countries (2013)
Journal of Infectious Diseases, 208 (12), 2075-2084 - Rates of new infections in British Columbia continue to decline at a faster rate than in other Canadian regions (2013)
HIV Medicine, 14 (9), 581-582 - Assessing the effectiveness of antiretroviral regimens in cohort studies involving HIV-positive injection drug users (2012)
AIDS, 26 (12), 1491-1500 - Clinical features, treatment, and outcome of HIV-associated immune thrombocytopenia in the HAART era (2012)
Advances in Hematology, 2012 - Cost-effectiveness of antiretroviral therapy for multidrug-resistant HIV: Past, present, and future (2012)
AIDS Research and Treatment, 2012 - Development and Validation of a Composite Programmatic Assessment Tool for HIV Therapy (2012)
PLoS ONE, 7 (11) - Disparities in the Burden of HIV/AIDS in Canada (2012)
PLoS ONE, 7 (11) - Factors predictive of 30-day postoperative mortality in HIV/AIDS patients in the era of highly active antiretroviral therapy (2012)
Annals of Surgery, 256 (1), 170-176 - Hiv treatment as prevention: Models, data, and questions-towards evidence-based decision-making (2012)
PLoS Medicine, 9 (7) - Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma (2012)
Leukemia and Lymphoma, 53 (12), 2390-2396 - Technical and regulatory shortcomings of the TaqMan version 1 HIV viral load assay (2012)
PLoS ONE, 7 (8) - The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: Collaborative cohort analysis (2012)
HIV Medicine, 13 (2), 89-97 - Treatment limitations imposed by antiretroviral drug resistance mutations: Implication for choices of first line regimens in resource-limited settings (2012)
HIV Medicine, 13 (3), 141-147 - Validating a shortened depression scale (10 item CES-D) among HIV-Positive people in British Columbia, Canada (2012)
PLoS ONE, 7 (7) - Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort (2011)
HIV Medicine, 12 (6), 352-360 - HIV incidence and prevalence among aboriginal peoples in Canada (2011)
AIDS and Behavior, 15 (1), 214-227 - Modelling the impact of antiretroviral therapy on the epidemic of HIV (2011)
Current HIV Research, 9 (6), 367-382 - Suboptimal use of HIV drug resistance testing in a universal health-care setting (2011)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 23 (1), 42-51 - The way I see it: The effect of stigma and depression on self-perceived body image among HIV-positive individuals on treatment in British Columbia,Canada (2011)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 23 (11), 1456-1466 - Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: An observational study (2011)
AIDS Research and Therapy, 8 - Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study (2010)
The Lancet, 376 (9740), 532-539 - Epidemiology of antiretroviral multiclass resistance (2010)
American Journal of Epidemiology, 172 (4), 460-468 - Evaluating outcomes of the President's Emergency Plan for AIDS Relief in Africa [2] (2010)
Annals of Internal Medicine, 152 (2), 131-132 - Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes (2010)
Journal of Acquired Immune Deficiency Syndromes, 55 (SUPPL. 1) - Expanding access to HAART: A cost-effective approach for treating and preventing HIV (2010)
AIDS, 24 (12), 1929-1935 - Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA guidelines in British Columbia, Canada (2010)
PLoS ONE, 5 (6) - Factors behind HIV testing practices among Canadian Aboriginal peoples living off-reserve (2010)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 22 (3), 324-331 - Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection (2010)
Clinical Infectious Diseases, 50 (1), 98-105 - Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme (2010)
HIV Medicine, 11 (5), 299-307 - Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population (2010)
Journal of Clinical Densitometry, 13 (4), 456-461 - Regional and temporal changes in HIV-related mortality in British Columbia, 1987-2006 (2010)
Canadian Journal of Public Health, 101 (5), 415-419 - Regional and temporal trends in migration among people living with HIV/AIDS in British Columbia, 1993-2005 (2010)
Canadian Journal of Public Health, 101 (1), 44-49 - Reply to 'Evidence is still required for treatment as prevention for riskier routes of HIV transmission' (2010)
AIDS, 24 (18), 2892-2893 - Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level (2010)
Journal of Acquired Immune Deficiency Syndromes, 55 (4), 460-465 - Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals. (2009)
American journal of public health, 99 Suppl 1 - Chylous ascites: A late complication of intra-abdominal Mycobacterium avium complex immune reconstitution syndrome in HIV-infected patients (2009)
International Journal of STD and AIDS, 20 (4), 285-287 - Does ratification of human-rights treaties have effects on population health? (2009)
The Lancet, 373 (9679), 1987-1992 - Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression (2009)
Journal of Acquired Immune Deficiency Syndromes, 52 (3), 357-363 - Epidemiology of treatment failure: A focus on recent trends (2009)
Current Opinion in HIV and AIDS, 4 (6), 467-473 - Erratum: Health care services utilization stratified by virological and immunological markers of HIV: Evidence from a universal health care settin (HIV Medicine (2009) vol. 10 (88-93)) (2009)
HIV Medicine, 10 (7), 459-459 - Health care services utilization stratified by virological and immunological markers of HIV: Evidence from a universal health care setting (2009)
HIV Medicine, 10 (2), 88-93 - HIV/AIDS in Vancouver, British Columbia: A growing epidemic (2009)
Harm Reduction Journal, 6 - Increased reporting of detectable plasma hiv-1 rna levels at the critical threshold of 50 copies per milliliter with the taqman assay in comparison to the amplicor assay (2009)
Journal of Acquired Immune Deficiency Syndromes, 51 (1), 3-6 - Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation (2009)
Journal of Clinical Pharmacology, 49 (2), 155-161 - Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients (2009)
Social Science and Medicine, 68 (6), 1044-1049 - Mortality is influenced by locality in a major HIV/AIDS epidemic (2009)
HIV Medicine, 10 (5), 274-281 - Orphanhood predicts delayed access to care in Ugandan children (2009)
Pediatric Infectious Disease Journal, 28 (2), 153-155 - Reconsidering first-line antiretroviral therapy in resource-limited settings: The need for operational research (2009)
Journal of Infectious Diseases, 199 (9), 1407-1408 - Safety and efficacy of once-daily nevirapine dosing: A multicohort study (2009)
Antiviral Therapy, 14 (7), 931-938 - The association between food insecurity and mortality among HIV-infected individuals on HAART (2009)
Journal of Acquired Immune Deficiency Syndromes, 52 (3), 342-349 - The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time (2009)
Journal of Acquired Immune Deficiency Syndromes, 50 (5), 529-536 - The WHOMEN's scale (women's HAART optimism monitoring and EvaluatioN scale v.1) and the association with fertility intentions and sexual behaviours among HIV-positive women in Uganda (2009)
AIDS and Behavior, 13 (SUPPL. 1) - Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis (2009)
The Lancet Infectious Diseases, 9 (7), 409-417 - Computerized adaptive testing in back pain: Validation of the CAT-5D-QOL (2008)
Spine, 33 (12), 1384-1390 - Differential impact of adherence on long-term treatment response among naive HIV-infected individuals (2008)
AIDS, 22 (17), 2371-2380 - Expanded access to highly active antiretroviral therapy: A potentially powerful strategy to curb the growth of the HIV epidemic (2008)
Journal of Infectious Diseases, 198 (1), 59-67 - Highly active antiretroviral therapy and survival in HIV-infected injection drug users (2008)
JAMA, 300 (5), 550-554 - Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting (2008)
Journal of Acquired Immune Deficiency Syndromes, 47 (4), 500-505 - Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy (2008)
Journal of Infectious Diseases, 198 (1), 51-58 - Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: Authors' reply (2008)
AIDS, 22 (4), 548-549 - Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency (2008)
AIDS, 22 (18), 2501-2508 - Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy (2007)
AIDS, 21 (6), 685-692 - Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients (2007)
AIDS, 21 (12), 1561-1568 - N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance (2007)
PLoS Medicine, 4 (12), 1887-1900 - Presenting plasma HIV RNA level and rate of CD4 T-cell decline [2] (2007)
JAMA, 297 (8), 805-806 - The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART (2007)
AIDS, 21 (9), 1175-1183 - Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART (2006)
AIDS Research and Therapy, 3 (1) - Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART (2006)
PLoS Medicine, 3 (9), 1570-1578 - Quantifying the effect of health status on health care utilization using a preference-based health measure (2005)
Social Science and Medicine, 60 (3), 515-524
Current Students & Alumni
If this is your researcher profile you can log in to the Faculty & Staff portal to update your details and provide recruitment preferences.
Membership Status
Location
Program Affiliations
Academic Unit(s)